Compositions and methods for eliciting an immune response to gram-negative bacterial infections

a technology for eliciting an immune response and gram-negative bacteria, which is applied in the direction of bacterial antigen ingredients, peptides, medical preparations, etc., can solve the problems of limited production of glycosylated pilin having o-antigens, and achieves stronger immune response, longer lasting immune response, and improved purity and processing

Inactive Publication Date: 2006-01-26
DUQUESNE UNIVERSITY
View PDF8 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0020] Further benefits of the present invention are derived from the nature of the immune response evoked when single O-antigen repeating units are attached to a pilin or other carrier protein. A covalent linkage of this glycan to pilin or other protein gives a stronger, longer lasting immune response because a T-cell-dependent process is evoked (as compared with the T-cell independent response evoked by LPS or detached O-antigen polysaccharide). When the O-antigen repeating unit is attached to pilin or other carrier protein, the size, orientation and organization of the epitope is different from that found on LPS, in which the O-antigen repeating units are arranged in chains. It is thought that the smaller O-antigen size evokes a stronger immune response. In addition, a smaller epitope can provide more interaction with B-cells per vaccine dose. Of particular significance is the availability of the O-antigen repeating unit terminal sugar residue in high molar ratio. The free terminal residue is only present once in each LPS or O-antigen polysaccharide.
[0021] Purity and processing are also improved in the present invention. For example, in addition to the absence of lipid A, glycosylated pili contain no contaminating protein or nucleic acids often found in LPS preparations. There is no LPS core present, so that only the target antigen is delivered, thus avoiding immune suppression problems. Additionally, no acid treatment is required, as is used in O-antigen polysaccharide production, which results in the destruction of certain O-antigens.
[0022] Importantly, using the methods of the present invention, glycan epitopes are amenable to engineering. For example, it is possible to produce pilins or carrier proteins having specific desired combinations of glycans from more than one source; epitopes that are most effective can be identified and used in a composition to elicit an immune response. These epitopes can be selectively bound to pilin or other carrier proteins so that they have derived epitopes which are not structurally similar, thus overcoming antigenic suppression problems seen in earlier multivalent LPS vaccines.
[0024] glycosylated pili can be produced in large amounts either from broth cultures or solid media. Purification of glycosylated pili is quickly accomplished, inexpensive and requires only common laboratory procedures.

Problems solved by technology

Thus this method required the use of host bacteria having pilin assembly mechanisms, namely type IV pili-producing bacteria, and was limited to the production of glycosylated pilin having O-antigens from these pilin-producing bacteria only.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for eliciting an immune response to gram-negative bacterial infections
  • Compositions and methods for eliciting an immune response to gram-negative bacterial infections
  • Compositions and methods for eliciting an immune response to gram-negative bacterial infections

Examples

Experimental program
Comparison scheme
Effect test

example 1

Cloned Serotype O11 O-Antigen Gene Cluster from P. aeruginosa PA103 Acts as O-antigen Source in P. aeruginosa 1244 LPS

[0139] In order to identify whether the O-antigen biosynthetic pathway serves as the source for the pilin glycan, a gene cluster encoding the O-antigen polysaccharides from serotype O11 of P. aeruginosa was moved into P. aeruginosa 1244 and tested for serotype-specific O-antigen expression on the LPS of this organism. The P. aeruginosa O11 O-antigen was chosen for the initial experiment because these genes have been isolated and characterized (Goldberg et al., 1992) and the O-antigen sugar residues are structurally very different from those found on the LPS of P. aeruginosa 1244. The P. aeruginosa O11 gene cluster is contained within a 15 Kb fragment on pLPS2 and was a gift from Dr. Joanna Goldberg (University of Virginia Health Sciences Center). This plasmid was conjugally transferred into P. aeruginosa 1244 by a triparental mating system described by Ruvkin and A...

example 2

Cloned Serotype O11 Gene Cluster from P. aeruginosa PA103 A cis as Pilin Glycan Source in P. aeruginosa 1244

[0141] Once O11 O-antigen expression was established on the LPS of P. aeruginosa 1244 / pLPS2, the pili of this organism were tested for the presence of the O11 O-polysaccharides. Since the LPS O-antigen ladder will mask pilin analysis, proteins were separated electrophoretically by isoelectric focusing. LPS is a highly negatively charged structure and therefore migrate off of a focusing gel. Pilin proteins separated in this manner successfully removes the LPS. Pilin from P. aeruginosa 1244 / pLPS2 was extracted from overnight plate cultures and suspended in 1% n-octyl-p-D-glucopyranoside (BOG). BOG is a nonioniic detergent intended for solublizing membrane bound proteins in their native state, hence was used in this procedure. Pilin was separated by isoelectric focusing in a pH gradient of 3.0-9.0, transferred to PVDF membrane by diffusion blotting, and reacted with strain 1244...

example 3

The Cloned E. coli O157:H7 O-antigen Gene Cluster Acts as the O-Antigen Source for P. aeruginosa 1244 LPS

[0146] To identify whether the E. coli O157:H7 O-antigen could be expressed on P. aeruginosa 1244 LPS, pDIG4, one of the newly constructed cosmids, was transferred into P. aeruginosa 1244 and tested for O-antigen expression. As with P. aeruginosa 1244 / pLPS2, two colonies from this mating were chosen for further analysis. Initially, confirmation of pDIG4 incorporation into P. aeruginosa 1244 was accomplished by performing a plasmid extraction on each Tc resistant colony (results not shown). The LPS from each 1244 strain harboring the pDIG4 plasmid was then extracted from overnight broth cultures, and tested by Western blot using mAb 11.14 (FIG. 12, panel A) and the E. coli O157:H7 specific antiserum (FIG. 12, panel B). This figure shows that strain 1244 / pDIG4 produces the usual O-antigen ladder that is observed in the wild type 1244 strain when analyzed with mAb 11.14 (panel A, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
resistanceaaaaaaaaaa
structureaaaaaaaaaa
Login to view more

Abstract

Compositions for eliciting an immune response against Gram-negative bacterial infections and methods of making such compositions are provided. The composition comprises glycosylated pilin, the pilin being glycosylated with the O-antigen of a target Gram-negative bacteria of interest. Methods of eliciting an immune response by administration of such compositions are also provided.

Description

FIELD OF THE INVENTION [0001] The present invention relates generally to compositions for eliciting an immune response against Gram-negative bacterial infections, methods of making such compositions, and methods of eliciting an immune response by administration of such compositions. BACKGROUND INFORMATION [0002] Bacterial sepsis and related septic shock are frequently lethal conditions caused by infection which can result from surgery, trauma, and immune suppression related to cancer, transplantation therapy or other diseases. Gram-negative bacterial infections comprise the most serious infectious disease problem seen in hospitals today, now counting for thousands of infections yearly with a high overall mortality. [0003] In prior decades, most infectious diseases contracted in hospitals were attributable to acute Gram-positive bacterial pathogens such as Staphylococcus and Streptococcus. However, in the last thirty years the incidence of nosocomial infections with Escherichia coli,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K39/00C12N1/21C07K14/21A61K39/07C12N15/09A61K39/108A61P31/04C07K1/02C07K14/195C07K14/435C07K14/77C12P19/26C12P21/02C12P21/08C12Q1/04C12R1/385
CPCA61K39/00C07K14/21A61K2039/55511A61P31/04
Inventor CASTRIC, PAUL
Owner DUQUESNE UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap